New treatment option for Breast Cancer Screening
Official title MADRE (Mammograms Available Due to Research and Education)
ClinicalTrials.gov ID: NCT05841355
What this study is testing
- What it's testing
- The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat Breast Cancer (BC) screening.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 74, women only. Healthy volunteers may be eligible.
You may be able to join if
- Aim 1
- female biological sex
- identification as Latinas
- non-adherence to USPSTF guidelines (42-74 years old, no mammogram in past 2 years, no previous BC diagnosis)
- no previous history of health volunteerism
You likely can't join if
- \ Not meeting at least one of the aforementioned Aim 1 inclusion criteria. Aim 2. Inclusion Criteria:
- female biological sex
- eligibility to obtain BC screenings by USPSTF guidelines (i.e., 40-74 years old, no personal BC history)
- referral from Aim 1 participants
- no previous history of health volunteerism
- no participation in the RCT (not an Aim 1 participant, no Session #3 attendance). Exclusion Criteria:
See the full eligibility criteria
- Aim 1
- female biological sex
- identification as Latinas
- non-adherence to USPSTF guidelines (42-74 years old, no mammogram in past 2 years, no previous BC diagnosis)
- no previous history of health volunteerism
- not a network member enrolled in Aim 2.
- \ Not meeting at least one of the aforementioned Aim 1 inclusion criteria. Aim 2. Inclusion Criteria:
- female biological sex
- eligibility to obtain BC screenings by USPSTF guidelines (i.e., 40-74 years old, no personal BC history)
- referral from Aim 1 participants
- no previous history of health volunteerism
- no participation in the RCT (not an Aim 1 participant, no Session #3 attendance). Exclusion Criteria:
- Not meeting at least one of the aforementioned Aim 1 inclusion criteria.
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 40 years to 74 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.